Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes milder side effects in patients. However, conventional dendritic cell (DC) ...

Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over expressed in the bone marrow and spleen in myelofibrosis. -- CK0804 engages with antigen presenting cells within ...

Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to receive a genetically modified pig kidney transplant.

Robust target engagement was observed, with statistically significant increases in regulatory T-cell (Treg) suppressive function and Treg numbers beginning as early as two weeks post-dosing and ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation across neurological diseases, offering new insights into disease mechanisms ...